Budget Control Act of 2011 could have a devastating effect on research

English: President Barack Obama signs the Budg...

English: President Barack Obama signs the Budget Control Act of 2011 in the Oval Office, Aug. 2, 2011. (Photo credit: Wikipedia)

Under the Budget Control Act of 2011, federal programs face an across-the-board funding cut of nearly 8 percent in January 2013, if Congress hasn’t reached agreement on a budget deficit reduction plan.

These across-the-board cuts could have a devastating effect on research and other programs of major importance to the rare disease community.

When Congress returns from its summer recess on September 10, we need to urge members of Congress to identify a solution to sequestration before we see a decline in medical research.

Senator Tom Harkin, Chairman of the Senate Appropriations Subcommittee on Labor, Health and Human Services, and Education, report discusses the potential impact on NIH and specific NIH initiatives such as the National Center for Advancing Translational Sciences.   The Harkin report details projected state-by-state impacts these automatic spending cuts, known as “sequestration”, would have.

It doesn’t mention FDA, but the potential impact on that agency would be equally devastating and could include:

  • the National Center for Advancing Translational Sciences would lose nearly $45 million
  • substantial cuts in the Orphan Product Research Grants program
  • significantly slower review times for new drugs, biologics and medical devices
  • reductions in planned new staffing for the rare disease offices in CDER and CBER
  • NIH would issue about 700 fewer grants to medical researchers in Fiscal Year 2013, which means 700 fewer opportunities to find medical treatments and cures;

For more information visit NORD (The National Organization for Rare Disorders) and sign up for their e-news at http://www.rarediseases.org/

Join NORD in advocacy at:http://capwiz.com/rarediseases/mlm/signup/
NORD is dedicated to helping the nearly 30 million Americans with rare diseases, and the organizations that serve them, through programs of education, advocacy, research, and patient services.

Resources:
http://www.rarediseases.org/advocacy/initiatives-updates
http://fastercures.blogspot.com/2012/08/sequestration-will-be-devastating-to.html

Advertisements
This entry was posted in ALS, Alzheimer's, Charcot-Marie-Tooth disease, Health CMT, human clinical trials, MS, neuromuscular disease, Parkinson's, peripheral neuropathy, Rare disease day, STAR, stem cell research and tagged , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s